Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in an infant who developed pancreatitis caused by meglumine antimoniate

Pediatric Infectious Disease Journal

Volumn 20, Issue 4, 2001, Pages 455-457

  Kuyucu, Necdet ^a,b   Kara, Cengiz ^a   Bakirtaç, Arzu ^a   Teziç, Tahsin ^a  

^a DR SAMI ULUS CHILDREN S HOSPITAL   (Turkey)

^b Cumhuriyet Mahallesi   (Turkey)

Author keywords

Allopurinol; Ketoconazole; Pancreatitis; Visceral leishmaniasis

Indexed keywords

ALLOPURINOL; KETOCONAZOLE; MEGLUMINE ANTIMONATE;

ARTICLE; CARDIOTOXICITY; CASE REPORT; COMBINATION CHEMOTHERAPY; DRUG CHOICE; HUMAN; INFANT; LIVER TOXICITY; MALE; NONHUMAN; PANCREATITIS; PRESCHOOL CHILD; PRIORITY JOURNAL; TREATMENT OUTCOME; VISCERAL LEISHMANIASIS;

ACUTE DISEASE; ALLOPURINOL; ANTIPROTOZOAL AGENTS; CHILD, PRESCHOOL; HUMANS; KETOCONAZOLE; LEISHMANIASIS, VISCERAL; MALE; MEGLUMINE; ORGANOMETALLIC COMPOUNDS; PANCREATITIS;

EID: 0035075692     PISSN: 08913668     EISSN: None     Source Type: Journal    
DOI: 10.1097/00006454-200104000-00021     Document Type: Article

References (21)

1. Leishmaniasis
2. Current approaches to leishmaniasis
3. Pancreatitis and palindromic arthropathy with effusions associated with sodium stibogluconate treatment in a renal transplant recipient
4. Successful treatment of visceral leishmaniasis with allopurinol plus ketoconazole in a renal transplant recipient after the occurrence of pancreatitis due to stibogluconate
5. Acute pancreatitis associated with the administration of meglumine antimoniate for the treatment of visceral leishmaniasis
6. Pancreatic necrosis following treatment of leishmaniasis with sodium stibogluconate
7. Meglumine antimoniate-induced pancreatitis
8. Pancreatitis induced by pentavalent antimonial agents during treatment of leishmaniasis
9. Misdiagnosis of pancreatitis in patients receiving treatment with pentavalent antimonial agents
10. Visceral leishmaniasis (kala-azar) in transplant recipients: Case report and review
11. High frequency of serious side effects from meglumine antimoniate given without an upper limit dose for the treatment of visceral leishmaniasis in human immunodeficiency virus type-1-infected patients
12. Human leishmaniasis: Clinical, diagnostic, and chemotherapeutic developments in the last 10 years
13. Leishmania species: Visceral (kala-azar), cutaneous, and mucosal leishmaniasis
14. Allopurinol in the treatment of visceral leishmaniasis
15. Evaluation of allopurinol in the treatment of kala azar occurring in North Bihar, India
16. Treatment of visceral leishmaniasis with meglumine and allopurinol
17. Ketoconazole in treatment of visceral leishmaniasis
18. Ketoconazole in the treatment of antimony-and pentamidine-resistant kala-azar
19. Ketoconazole in visceral leishmaniasis
20. Fluconazole plus allopurinol in treatment of visceral leishmaniasis
21. The renal transplant patient with visceral leishmaniasis who could not tolerate meglumine antimoniate: Cure with ketoconazole and allopurinol